2017
DOI: 10.1080/1061186x.2017.1363215
|View full text |Cite
|
Sign up to set email alerts
|

The AGMA1 polyamidoamine mediates the efficient delivery of siRNA

Abstract: AGMA1, a prevailingly cationic, guanidine-bearing, linear, amphoteric polyamidoamine is an effective siRNA condensing agent. Here two AGMA1 samples of different molecular weight, i.e. AGMA1-5 and AGMA1-10 were evaluated as siRNA condensing agents and transfection promoters. AGMA1-10 formed stable polyplexes with a size lower than 50 nm and positive zeta potential. AGMA1-5 polyplexes were larger, about 100 nm in size. AGMA1-10 polyplexes, but not AGMA1-5 proved to be an effective intracellular siRNA carrier, ab… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
14
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
9

Relationship

5
4

Authors

Journals

citations
Cited by 15 publications
(14 citation statements)
references
References 46 publications
0
14
0
Order By: Relevance
“…M n 7800 AGMA1/siRNA polyplexes induced Akt1 gene silencing in HeLa and PC3 cells. The transfection efficiency was comparable with that of commercial siRNA transfection promoters, as for instance JetPEIVR and OligofectamineVR [116].…”
Section: Paas As Dna/sirna Transfection Promotersmentioning
confidence: 59%
“…M n 7800 AGMA1/siRNA polyplexes induced Akt1 gene silencing in HeLa and PC3 cells. The transfection efficiency was comparable with that of commercial siRNA transfection promoters, as for instance JetPEIVR and OligofectamineVR [116].…”
Section: Paas As Dna/sirna Transfection Promotersmentioning
confidence: 59%
“…In addition, siRNA complexation with cationic polymers via electrostatic interactions has been largely studied [56][57][58]. However, this approach suffers from some limitations, such as the stability issue in biological fluids, low transfection efficiency, and toxicity problems [45,55,59].…”
Section: Characterization Of Sinrf2-nanobubble Formulationsmentioning
confidence: 99%
“…PAAs were previously investigated as anticancer drug carriers (Lavignac et al, 2009). In particular, the PAA nicknamed AGMA1 can be used as a potential non-viral, non-toxic and efficient vector for the intracellular delivery of siRNA and DNA (Cavalli et al, 2010;Cavalli et al, 2017). Interestingly, AGMA1, containing tert-amine, carboxyl and guanidine groups, whose repeat unit is reminiscent of the arggly-asp (RGD) peptide motif (Franchini et al, 2006), a wellknown fibronectin sequence mediating cell attachment, can act as an excellent cell adhesion and proliferation substrate (Gualandi et al, 2016).…”
Section: Introductionmentioning
confidence: 99%